Your Blood Sugar Just Got a Streaming Service

For most of your life, watching your glucose numbers in real time meant one thing: you had diabetes, and your doctor wrote a prescription. That gatekeeping is over. Stelo, Lingo, and Levels are now selling continuous glucose monitors to anyone over 18 who wants to see how pizza, a bad night’s sleep, or that morning run actually moves their metabolism. And honestly, it’s worth understanding what you’re actually getting before you strap a sensor under your skin.

Here’s the simple version: a continuous glucose monitor is a tiny wearable that measures glucose levels 24/7 through a sensor just under the skin, streaming the data straight to your phone. No finger pricks. No guessing. Just real-time trends that show you exactly how your body responds to food, exercise, stress, and sleep. It sounds like science fiction, but it’s happening right now.

The three players in the ring each have different philosophies. Stelo, made by Dexcom, is the straightforward option—no prescription needed, 15-day wear time, designed for people not on insulin who want to understand their glucose patterns. Lingo is all about speed, refreshing every single minute instead of every 15, with the app pairing your glucose data with science-backed habit-building tips. Levels takes the widest view, combining CGM data with lifestyle tracking and biomarker testing to surface patterns in glucose spikes and insulin sensitivity. Think of it like the difference between a pedometer, a fitness tracker, and a full biometric dashboard.

The critical asterisk here: these sensors aren’t a substitute for medical advice, and the wellness marketing around them can blur that line. The American Diabetes Association is clear—CGMs can help prevent serious complications, save money through better management, and give you real-time feedback to adjust your diet and behavior. But that feedback only matters if you know how to use it. The ADA’s advice is simple: talk to your doctor or a diabetes educator before choosing. They’ll help you pick the right system and actually understand what your data means.

The barrier to entry has dropped, which is genuinely good news for people with prediabetes, obesity, or other metabolic conditions who previously had no way to see their glucose in action. The stakes are real. But with that access comes responsibility—a sensor on your arm isn’t the same as a plan to use it well. That’s on you and your healthcare provider to figure out together.